Rituximab

Guidelines for Biologics Use in Lupus by International Panel

Guidelines for Biologics Use in Lupus by International Panel

By

A multidisciplinary group of international experts has released recommendations for the use of biologics in patients with systemic lupus erythematosus.

First Clinical Practice Guidelines for Sjögren's Syndrome

First Clinical Practice Guidelines for Sjögren's Syndrome

By

The Sjögren's Syndrome Foundation has released the first clinical practice guidelines for the disease, which includes recommendations on the management of fatigue, inflammatory musculoskeletal pain, and use of biologic agents.

Rituximab Shows Promise for Refractory Myasthenia Gravis

Rituximab Shows Promise for Refractory Myasthenia Gravis

Most patients required a least a year to completely withdraw from immunotherapy in order to demonstrate a clinical remission.

Sign Up for Free e-Newsletters